Acetaminophen safety and hepatotoxicity – where do we go from here?
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Acetaminophen has been widely used for > 50 years in the treatment of pain and fever and provides for the safe and effective relief of these symptoms. In a small minority of patients, however, acetaminophen is responsible for life-threatening liver injury and accounts for up to 50% of all adult cases of acute liver failure in the US. Although approximately two-thirds of adult overdoses are associated with suicide attempts, many are inadvertent, often due to the use of multiple acetaminophen formulations over many days. Additionally, some individuals appear to experience acetaminophen toxicity at 'therapeutic' doses of < 4 g/day, for reasons unknown. In pediatric populations, the overwhelming majority of acetaminophen overdoses are due to unintentional overdoses, except for the predominance of suicidal ingestions in the teenage population. This article seeks to review the mechanism and metabolism of acetaminophen and the features of toxicity in adults, pediatric and special populations. Additionally, expert opinion is presented herein to aid in reducing the frequency and severity of liver injury from acetaminophen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Mechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648
Acetaminophen Poisoning and Toxicity
Rumack, B. H., & Matthew, H. (1975) · Pediatrics · doi:10.1542/peds.55.6.871 · Cited by 640 · cited 1×
“The APAP overdose nomogram ( Figure 2 ) was developed in 1975 for the evaluation of acute overdoses of APAP [24] .”
MethodAssociation of Acetaminophen Hepatotoxicity With Fasting and Ethanol Use
Whitcomb, D. C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520230055038 · Cited by 470
Acetaminophen Hepatotoxicity in Alcoholics: A Therapeutic Misadventure
SEEFF, L. B., CUCCHERINI, B. A., ZIMMERMAN, H. J., ADLER, E., & BENJAMIN, S. B. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-399 · Cited by 424
Acetaminophen Toxicity in an Urban County Hospital
Schiødt, F. V., Rochling, F. A., Casey, D. L., & Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371602 · Cited by 422
Moore, M., Thor, H., Moore, G., Nelson, S., Moldéus, P., & Orrenius, S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38834-8 · Cited by 410 · cited 1×
“Although NAPQI can attack certain critical protein thiols [18] , leading to cellular injury, it may also predispose cells to oxidative damage from superoxide dismutase [19] and nitric oxide [20] .”
BackgroundHawton, K., Townsend, E., Deeks, J., Appleby, L., Gunnell, D., Bennewith, O., & Cooper, J. (2001) · BMJ · doi:10.1136/bmj.322.7296.1203 · Cited by 383
Measurement of Serum Acetaminophen–Protein Adducts in Patients With Acute Liver Failure
Davern, T. J., James, L. P., Hinson, J. A., Polson, J., Larson, A. M., Fontana, R. J., Lalani, E., Munoz, S., Shakil, A. O., & Lee, W. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.033 · Cited by 284
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
Ottani, A., Leone, S., Sandrini, M., Ferrari, A., & Bertolini, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.015 · Cited by 279 · cited 1×
“Additionally, studies have suggested modulation of the 5-HT seritoninergic [8,9] and CB1 cannabin [10] systems as part of the analgesic effects of APAP, although the significance of these findings is unclear.”
BackgroundBoutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209
THE FATE OF ACETANILIDE IN MAN
Brodie, B. B., & Axelrod, J. (1948) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03462-7 · Cited by 168 · cited 1×
“This discovery by Axelrod and Brodie [1] in 1948 led to the recommendation that APAP replace acetanilide as an analgesic and was a critical milestone leading to the launching of Tylenol, in 1955, in the US and Panadol ® (GlaxoSmithKline), in 1956, in the UK.”
BackgroundMechanism of Acetaminophen Inhibition of Cyclooxygenase Isoforms
Ouellet, M., & Percival, M. D. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2232 · Cited by 166 · cited 1×
“This difference accounts for the relative lack of anti-inflammatory [11] or antithrombotic effects of APAP, as compared with NSAIDs.”
BackgroundFeldberg, W., Gupta, K. P., Milton, A. S., & Wendlandt, S. (1973) · The Journal of Physiology · doi:10.1113/jphysiol.1973.sp010346 · Cited by 165
Dose-dependent pharmacokinetics of acetaminophen: Evidence of glutathione depletion in humans
Slattery, J. T., Wilson, J. M., Kalhorn, T. F., & Nelson, S. D. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.50 · Cited by 143
Acetaminophen Inhibits Spinal Prostaglandin E2Release after Peripheral Noxious Stimulation
Muth-Selbach, U. S., Tegeder, I., Brune, K., & Geisslinger, G. (1999) · Anesthesiology · doi:10.1097/00000542-199907000-00032 · Cited by 142 · cited 1×
“The inhibition of prostaglandins in the CNS is thought to be responsible for many of the effects of APAP [5,6] resulting in an elevation in the pain threshold [7] as well as direct action in the hypothalamus resulting in its antipyretic effects.”
BackgroundAlloui, A., Chassaing, C., Schmidt, J., Ardid, D., Dubray, C., Cloarec, A., & Eschalier, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01578-9 · Cited by 83
Bonnefont, J., Alloui, A., Chapuy, E., Clottes, E., & Eschalier, A. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00034 · Cited by 74
Pharmacokinetics of Zidovudine and Acetaminophen in a Patient on Chronic Acetaminophen Therapy
Burger, D. M., Meenhorst, P. L., Koks, C. H. W., & Beijnen, J. H. (1994) · Annals of Pharmacotherapy · doi:10.1177/106002809402800306 · Cited by 7
Cited by
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
“If misused, either intentionally or accidentally, acetaminophen can cause significant liver injury (5, 6).”
BackgroundMachado, G. C., Maher, C. G., Ferreira, P. H., Pinheiro, M. B., Lin, C.-W. C., Day, R. O., McLachlan, A. J., & Ferreira, M. L. (2015) · BMJ · doi:10.1136/bmj.h1225 · Cited by 580
Casamassimo, P. S., Thikkurissy, S., Edelstein, B. L., & Maiorini, E. (2009) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2009.0250 · Cited by 510
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses
Mazaleuskaya, L. L., Sangkuhl, K., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000150 · Cited by 379
Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand
Chiew, A. L., Reith, D., Pomerleau, A., Wong, A., Isoardi, K. Z., Soderstrom, J., & Buckley, N. A. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50428 · Cited by 145
Metadata
- Authors
- Amar, P. J., & Schiff, E. R.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2007-07
- Volume
- 6
- Issue
- 4
- Pages
- 341-355
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2110155172
- Cited by
- 112
- References
- 20
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.